Phencyclidine interferes with the hippocampal gating of nucleus accumbens neuronal activity in vivo

Neuroscience

Volumn 87, Issue 4, 1998, Pages 823-830

  O'Donnell, P ^a   Grace, A A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Electrophysiology; In vivo intracellular recordings; PCP; Schizophrenia; Subiculum

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATAXIA; CONTROLLED STUDY; HIPPOCAMPUS; IN VIVO STUDY; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; STEREOTYPY;

ACTION POTENTIALS; AFFERENT PATHWAYS; ANIMALS; EXCITATORY AMINO ACID ANTAGONISTS; HALLUCINOGENS; HIPPOCAMPUS; MALE; MEMBRANE POTENTIALS; NEURONS; NUCLEUS ACCUMBENS; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA;

EID: 0032543982     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00190-0     Document Type: Article

References (50)

1. Albin R. L., Makoviec R. L., Hollingsworth Z. R., Dure L. S., Penney J. B., Young A. B. Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience. 46:1991;35-48.
2. Bakshi V. P., Geyer M. A. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology. 122:1995;198-201.
3. Bakshi V. P., Swerdlow N. R., Geyer M. A. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J. Pharmac. exp. Ther. 271:1994;787-794.
4. Barta P. E., Pearlson G. D., Powers R. E., Richards S. S., Tune L. E. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am. J. Psychiat. 147:1990;1457-1462.
5. Berman K. F., Zec R. F., Weinberger D. R. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Archs gen. Psychiat. 43:1986;126-135.
6. Boyce S., Rupniak N. M. J., Steventon M. J., Cook G., Iversen S. D. Psychomotor activity and cognitive disruption attributable to NMDA, but not sigma, interactions in primates. Behav. Brain Res. 42:1991;115-121.
7. Braff D. L., Grillon C., Geyer M. A. Gating and habituation of the startle reflex in schizophrenic patients. Archs gen. Psychiat. 49:1992;206-215.
8. Bunney B. G., Bunney W. E. and Carlsson A. (1995) Schizophrenia and glutamate. In Psychopharmacology: The Fourth Generation of Progress (eds Bloom F. E. and Kupfer D. J.), pp. 1205-1214. Raven, New York.
9. Carlsson M., Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13:1990;272-276.
10. Castellani S., Adams P. M. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur. J. Pharmac. 73:1981;143-154.
11. Chen G., Ensor C. R., Russell D., Bohner B. The pharmacology of 1-(1-phenylcyclohexyl)piperidine-HCl. J. Pharmac. exp. Ther. 127:1959;241-250.
12. Chiodo L. A., Bunney B. S. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J. Neurosci. 3:1983;1607-1619.
13. Corbett R., Camacho F., Woods A. T., Kerman L. L., Fishkin R. J., Brooks K., Dunn R. W. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology. 120:1995;67-74.
14. Davies B. M., Beech H. R. The effect of L-arylcyclohexylamine (Sernyl) on twelve normal volunteers. J. mental Sci. 106:1960;912-924.
15. Frederick D. L., Gillam M. P., Allen R. R., Paule M. G. Acute behavioral effects of phencyclidine on Rhesus monkey performance in an operant test battery. Pharmac. Biochem. Behav. 52:1995;789-797.
16. Grace A. A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 41:1991;1-24.
17. Grace A. A. The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia. J. neural Transm. 36:1992;91-131.
18. Grace A. A., Moore H. M. Gap junction inactivation in the striatum prevents oral stereotypy induced by apomorphine. Soc. Neurosci. Abstr. 22:1996;1088.
19. Haggerty G. C., Forney R. B., Johnson J. M. The effect of a single administration of phencyclidine on behavior in the rat over a 21-day period. Toxicol. appl. Pharmac. 75:1984;444-453.
20. Honey C. R., Miljovic Z., MacDonald J. F. Ketamine and phencyclidine cause a voltage-dependent block of responses to L-aspartic acid. Neurosci. Lett. 61:1985;135-139.
21. Jarrard L. E. What does the hippocampus really do? Behav. Brain Res. 71:1995;1-10.
22. Javitt D. C., Zukin S. R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiat. 148:1991;1301-1308.
23. Johansson C., Jackson D. M., Svensson L. The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat. Psychopharmacology. 116:1994;437-442.
24. Johansson O. and Hökfelt T. (1981) Nucleus accumbens: transmitter histochemistry with special reference to peptide-containing neurons. In The Neurobiology of the Nucleus Accumbens. (eds Chronister R. B. and DeFrance J. F.), pp. 147-171. Hauer Institute, Brunswick, Maine.
25. Kelley A. E., Domesick V. B. The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: an anterograde- and retrograde-horseradish peroxidase study. Neuroscience. 7:1982;2321-2335.
26. Kesner R. P., Davis M. Phencyclidine disrupts acquisition and retention performance within a spatial continuous recognition memory task. Pharmac. Biochem. Behav. 44:1993;419-424.
27. Kesner R. P., Hardy J. D., Calder L. D. Phencyclidine and behavior: I. Sensory-motor function, activity level, taste aversion and water intake. Pharmac. Biochem. Behav. 15:1981;7-13.
28. Kovelman J. A., Scheibel A. B. A neurohistological correlate of schizophrenia. Biol. Psychiat. 19:1984;1601-1917.
29. Lavín A., Grace A. A. The modulation of mediodorsal and dorsal thalamic nuclei by the ventral pallidum: its role in the regulation of thalamocortical activity in the basal ganglia. Synapse. 18:1994;104-127.
30. Lehmann-Masten V. D., Geyer M. A. Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats. Neuropharmacology. 30:1991;629-636.
31. Luby E. D., Cohen B. D., Rosenbaum G., Gottlieb J. S., Kelly R. Study of a new schizophrenomimetic drug - Sernyl. Archs neurol. psychiat. 81:1959;363-369.
32. McCullough L. D., Salamone J. D. Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens. Brain Res. 577:1992;1-9.
33. Murray T. F., Horita A. Phencyclidine-induced stereotyped behavior in rats: dose response effects and antagonism by neuroleptics. Life Sci. 24:1979;2217-2226.
34. O'Donnell P., Grace A. A. Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J. Neurosci. 15:1995;3622-3639.
35. O'Donnell P., Grace A. A. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schiz. Bull. 24:1997;267-283.
36. O'Donnell P., Lavín A., Enquist L. W., Grace A. A., Card J. P. Interconnected parallel circuits between rat nucleus accumbens and thalamus revealed by retrograde transynaptic transport of pseudorabies virus. J. Neurosci. 17:1997;2143-2167.
37. Paxinos G. and Watson C. (1997) The Rat Brain in Stereotaxic Coordinates, 3rd edn. Academic, San Diego.
38. Pennartz C. M. A., Kitai S. T. Hippocampal inputs to identified neurons in an in vitro slice preparation of the rat nucleus accumbens: evidence for feed-forward inhibition. J. Neurosci. 11:1991;2838-2847.
39. Russell J. W., Greenberg B. D., Segal D. S. The effects of phencyclidine on spontaneous aggressive behavior in the rat. Biol. Psychiat. 19:1984;195-202.
40. Sams-Dodd F. Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment. J. Neurosci. Meth. 59:1995;157-167.
41. Sams-Dodd F. Distinct effects of D-amphetamine and phencyclidine on the social behaviour of rats. Behav. Pharmac. 6:1995;55-65.
42. Sams-Dodd F. Phencyclidine-induced stereotyped behavior and social isolation in rats: a possible animal model of schizophrenia. Behav. Pharmac. 7:1996;3-23.
43. Steinpreis R. E., Sokolowski J. D., Papanikolau A., Salamone J. D. The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat. Pharmac. Biochem. Behav. 47:1994;579-585.
44. Uchimura N., Higashi H., Nishi S. Membrane properties and synaptic responses of the guinea pig nucleus accumbens neurons in vitro. J. Neurophysiol. 61:1989;769-779.
45. Walaas I., Fonnum F. Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain. Neuroscience. 5:1980;1691-1698.
46. Weinberger D. R. Schizophrenia and the frontal lobe. Trends Neurosci. 11:1988;367-370.
47. Weinberger D. R. From neuropathology to neurodevelopment. Lancet. 346:1995;552-557.
48. Weinberger D. R., Berman K. F., Suddath R., Torrey E. F. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am. J. Psychiat. 149:1992;890-897.
49. White F. J., Wang R. Y. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science. 221:1983;1054-1057.
50. Wood P. L., Steel D., McPherson S. E., Cheney D. L., Lehman J. Antagonism of N-methyl-D-aspartate (NMDA) evoked increases in cerebellar cGMP and striatal Ach release by phencyclidine (PCP) receptor agonists: evidence for possible allosteric coupling of NMDA and PCP receptor. Can. J. Physiol. Pharmac. 65:1987;1923-1927.